GlassScriptPhysician profile
Matthew Taub
NPI 1396784807
$32,282.42
in general payments reported to CMS, 2019-2025
93 companies · $5,631 in 2025
The $5,631 reported for 2025 was more than what 83% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,990 · 2020: $3,246 · 2021: $5,633 · 2022: $4,388 · 2023: $5,176 · 2024: $5,218 · 2025: $5,631.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16K · Education: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,809.80 |
| Education | $215.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,782.14 | 2019-2025 | |
| Pfizer INC. | $2,357.09 | 2019-2025 | |
| Janssen Biotech, INC. | $2,221.93 | 2019-2025 | Darzalex, Tecvayli, Imbruvica |
| Astrazeneca Pharmaceuticals LP | $2,056.66 | 2019-2025 | Lynparza, Tagrisso, Imfinzi |
| Celgene Corporation | $1,621.59 | 2019-2025 | Reblozyl, Pomalyst, Pomalyst |
| Pharmacosmos Therapeutics INC. | $1,556.03 | 2021-2024 | Cosela |
| E.R. Squibb & Sons, L.L.C. | $1,546.18 | 2019-2025 | Opdivo, Opdualag, Krazati |
| Merck Sharp & Dohme LLC | $1,246.82 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Rigel Pharmaceuticals, INC. | $1,030.82 | 2019-2025 | Gavreto, Rezlidhia, Tavalisse |
| Daiichi Sankyo INC. | $1,021.60 | 2019-2025 | Injectafer, Enhertu, Datroway |
| Amgen INC. | $711.12 | 2019-2025 | Xgeva, Vectibix, Kyprolis |
| Genentech USA, INC. | $701.42 | 2019-2025 | Polivy, Venclexta, Alecensa |
| Abbvie INC. | $616.03 | 2021-2025 | Venclexta |
| Seagen INC. | $603.16 | 2019-2023 | Tukysa, Padcev, Tivdak |
| Genzyme Corporation | $547.34 | 2020-2025 |
Show all 93 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $531.03 | 2021-2025 | Ojjaara, Shingrix, Blenrep |
| Incyte Corporation | $529.68 | 2020-2025 | Jakafi |
| Karyopharm Therapeutics INC. | $527.74 | 2020-2025 | Xpovio |
| Myriad Genetic Laboratories, INC. | $524.48 | 2021-2025 | Myrisk, Precisetumor |
| Array Biopharma INC | $499.57 | 2020-2025 | Braftovi, Mektovi, Lorbrena |
| Takeda Pharmaceuticals U.S.A., INC. | $470.98 | 2019-2025 | Alunbrig, Iclusig, Ninlaro |
| Taiho Oncology, INC. | $406.55 | 2019-2025 | |
| Emd Serono, INC. | $404.12 | 2021-2025 | Tepmetko, Bavencio |
| Lilly USA, LLC | $385.74 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Eisai INC. | $363.35 | 2021-2025 | |
| Tempus Ai, INC | $360.91 | 2024-2025 | Xt Cdx |
| Kite Pharma, INC. | $348.00 | 2020-2025 | Yescarta |
| Adaptive Biotechnologies Corporation | $345.17 | 2022-2025 | Clonoseq |
| Pharmaessentia USA Corporation | $337.48 | 2022-2025 | Besremi |
| Bayer Healthcare Pharmaceuticals INC. | $321.76 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $302.86 | 2021-2025 | Libtayo, Lynozyfic |
| Beigene USA, INC. | $287.32 | 2022-2025 | Brukinsa |
| Stemline Therapeutics INC. | $269.55 | 2023-2025 | Orserdu |
| Astellas Pharma US INC | $248.39 | 2019-2025 | Padcev, Xtandi, Xospata |
| Dova Pharmaceuticals | $211.14 | 2019-2021 | |
| Aveo Pharmaceuticals, INC. | $202.24 | 2024-2025 | |
| Alexion Pharmaceuticals, INC. | $177.47 | 2023-2025 | Ultomiris |
| Exelixis INC. | $176.50 | 2019-2025 | Cabometyx |
| Caris Mpi, INC. | $161.97 | 2025 | Mi Cancer Seek |
| Fennec Pharmaceuticals, INC. | $159.91 | 2024-2025 | Fyarro, Pedmark |
| Sobi, INC | $157.14 | 2025 | |
| Mirati Therapeutics, INC. | $140.64 | 2023 | Krazati |
| Teva Pharmaceuticals USA, INC. | $139.07 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $130.01 | 2020-2024 | |
| Gilead Sciences, INC. | $123.44 | 2021-2025 | Trodelvy |
| Global Blood Therapeutics, INC. | $106.75 | 2020-2022 | |
| Octapharma USA, INC. | $106.37 | 2020-2024 | Octagam Immune Globulin (Human) |
| Beone Medicines USA, INC. | $99.46 | 2025 | Brukinsa |
| Geron Corporation | $98.50 | 2025 | Rytelo |
| Tersera Therapeutics LLC | $98.44 | 2021-2025 | Zoladex, Xermelo, Quzyttir |
| Ipsen Biopharmaceuticals, INC | $93.95 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $90.44 | 2019-2020 | |
| Kyowa Kirin, INC. | $85.11 | 2019-2024 | Poteligeo |
| Boston Scientific Corporation | $83.93 | 2022-2025 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Amneal Pharmaceuticals LLC | $80.95 | 2025 | Alymsys |
| Emmaus Medical, INC. | $73.65 | 2019-2023 | Endari |
| Agios Pharmaceuticals, INC. | $70.34 | 2022-2025 | Pyrukynd |
| Mylan Institutional INC. | $68.30 | 2019-2022 | |
| Clovis Oncology, INC. | $67.58 | 2021-2022 | |
| Cti Biopharma Corp. | $65.36 | 2023 | Vonjo |
| Deciphera Pharmaceuticals INC. | $64.36 | 2021-2023 | Qinlock |
| Pharmacyclics LLC, An Abbvie Company | $61.89 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $61.05 | 2019-2022 | |
| Epizyme, INC. | $60.42 | 2020-2021 | |
| Apellis Pharmaceuticals, INC. | $56.45 | 2023-2025 | Empaveli |
| Azurity Pharmaceuticals, INC. | $48.86 | 2025 | Danziten |
| Aurobindo Pharma USA, INC. | $45.62 | 2019-2020 | |
| Iovance Biotherapeutics, INC. | $44.69 | 2025 | Amtagvi |
| Organon LLC | $44.67 | 2021-2022 | |
| Adc Therapeutics America, INC. | $43.73 | 2024-2025 | |
| Myovant Sciences INC. | $42.46 | 2022 | |
| Dendreon Pharmaceuticals LLC | $38.87 | 2025 | Provenge |
| Coherus Oncology, INC. | $37.98 | 2024 | |
| Sirtex Medical INC | $37.00 | 2020-2024 | Sir-Spheres Microspheres |
| Menarini Silicon Biosystems, INC. | $34.85 | 2024-2025 | |
| Eusa Pharma (US) LLC | $34.53 | 2021-2022 | |
| Helsinn Therapeutics (U.S.), INC. | $34.22 | 2019 | |
| Ge Healthcare | $28.83 | 2022 | |
| Alnylam Pharmaceuticals INC. | $27.15 | 2021 | |
| Sumitomo Pharma America, INC. | $26.39 | 2024 | Orgovyx |
| Legend Biotech USA INC. | $24.62 | 2025 | Carvykti |
| Invivyd INC | $23.55 | 2025 | Pemgarda |
| G1 Therapeutics, INC. | $23.40 | 2022 | |
| Corcept Therapeutics | $22.45 | 2025 | Korlym |
| Genmab U.S., INC. | $21.79 | 2023 | Epkinly |
| Blueprint Medicines Corporation | $21.12 | 2025 | Ayvakit |
| Spectrum Pharmaceuticals INC. | $20.32 | 2025 | Rolvedon |
| Cumberland Pharmaceuticals, INC. | $20.28 | 2023 | Sancuso |
| Shire North American Group INC | $17.02 | 2019 | |
| Verastem, INC. | $16.24 | 2020 | |
| Advanced Accelerator Applications | $16.17 | 2020 | |
| Sanofi-Aventis U.S. LLC | $14.46 | 2021 | |
| Stryker Corporation | $13.71 | 2023 | Ortholoc 2 Lapifuse |
Drugs and devices associated with these payments
Darzalex $573Keytruda $561Reblozyl $551Lynparza $487Xtandi $456Imbruvica $449Venclexta $416Injectafer $402Pomalyst $396Talzenna $359Tecvayli $350Enhertu $346Myrisk $344Ojjaara $336Brukinsa $326Xt Cdx $322Xpovio $318Tukysa $304Inlyta $302Besremi $297Talvey $280Tagrisso $272Orserdu $270Lutathera $261Clonoseq $260Bosulif $244Braftovi $241Ibrance $235Inqovi $224Lonsurf $224Lorbrena $221Kisqali $213Krazati $206Orgovyx $205Erleada $205Lenvima $204Fotivda $202Jakafi $201Vonjo $196Mektovi $193Fabhalta $192Opdivo $188Elrexfio $186Imfinzi $183Ultomiris $177Carvykti $175Nubeqa $169Pluvicto $166Libtayo $164Mi Cancer Seek $162Tepmetko $161Padcev $159Adcetris $148Xofigo $147Comirnaty $146Epkinly $137Xalkori $134Rybrevant $132Welireg $131Polivy $126Precisetumor $112Scemblix $110Sarclisa $104Rytelo $98.50Oxbryta $96.52Alunbrig $92.02Fyarro $90.33Datroway $85.91Cabometyx $85.17Opdualag $84.85Iclusig $84.71Bavencio $84.03Paxlovid $82.77Alymsys $80.95Tivdak $76.55Poteligeo $72.06Pedmark $69.58Trodelvy $67.92Piqray $67.81Tasigna $66.86Promacta $64.53Besponsa $62.25Empaveli $56.45Therasphere Y90 Glass Microspheres 10 Gbq $56.41Cablivi $56.02Jaypirca $52.01Verzenio $52.01Kyprolis $50.99Tavalisse $48.99Rezlidhia $48.99Gavreto $48.99Danziten $48.86Ninlaro $46.74Fruzaqla $46.16Elahere $45.76Stivarga $44.71Amtagvi $44.69Akeega $43.42Zepzelca $41.99Alecensa $41.49
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Taub listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.